GoodRx Holdings Inc (GDRX)

Precedente Chiudi:

$7.08

Aprire:

$7.28

Volume 24 ore:

910.09K

Capitalizzazione di mercato:

$2.84B

Reddito:

$750.27M

Utile/perdita netta:

$-8.87M

Rapporto P/E:

285.32

EPS:

0.0252

Flusso di cassa netto:

$82.53M

1 W Prestazione:

+7.47%

1M Prestazione:

+1.84%

6M Prestazione:

+37.21%

1 anno Prestazione:

+47.94%

Intervallo 1D:

$7.09

$7.35

Portata 52W:

$4.135

$9.37

GoodRx Holdings Inc Stock (GDRX) Company Profile

Nome

GoodRx Holdings Inc

Settore

Healthcare (1191)

Industria

Health Information Services (62)

Telefono

855 268 2822

Indirizzo

233 Wilshire Boulevard, Suite 990, Santa Monica

Dipendente

338

Cinguettio

Prossima data di guadagno

2024-05-15

Ultimi documenti SEC

GDRX's Discussions on Twitter

GoodRx Holdings Inc Stock (GDRX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-01-02	Downgrade	BofA Securities	Buy → Underperform
2023-08-10	Aggiornamento	DA Davidson	Neutral → Buy
2023-07-31	Aggiornamento	TD Cowen	Market Perform → Outperform
2022-12-01	Iniziato	Citigroup	Buy
2022-11-04	Aggiornamento	JP Morgan	Underweight → Neutral
2022-09-16	Iniziato	KeyBanc Capital Markets	Sector Weight
2022-09-07	Iniziato	Truist	Hold
2022-08-12	Iniziato	DA Davidson	Neutral
2022-06-10	Downgrade	Goldman	Buy → Neutral
2022-06-06	Ripresa	BofA Securities	Buy
2022-06-01	Downgrade	Robert W. Baird	Outperform → Neutral
2022-05-10	Downgrade	Evercore ISI	Outperform → In-line
2022-05-10	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
2022-05-10	Downgrade	Raymond James	Outperform → Mkt Perform
2022-05-10	Downgrade	SVB Leerink	Outperform → Mkt Perform
2022-04-11	Iniziato	Wells Fargo	Equal Weight
2022-04-07	Iniziato	Guggenheim	Buy
2022-04-01	Ripresa	Credit Suisse	Neutral
2022-03-15	Aggiornamento	Robert W. Baird	Neutral → Outperform
2022-03-01	Reiterato	Barclays	Overweight
2022-03-01	Reiterato	BofA Securities	Neutral
2022-03-01	Downgrade	Cowen	Outperform → Market Perform
2022-03-01	Downgrade	Credit Suisse	Outperform → Neutral
2022-03-01	Reiterato	Evercore ISI	Outperform
2022-03-01	Reiterato	Goldman	Buy
2022-03-01	Reiterato	JP Morgan	Underweight
2022-03-01	Reiterato	RBC Capital Mkts	Outperform
2022-03-01	Reiterato	SVB Leerink	Outperform
2022-01-07	Iniziato	Goldman	Buy
2021-12-21	Iniziato	Stephens	Overweight
2021-12-02	Iniziato	Jefferies	Buy
2021-08-31	Aggiornamento	Barclays	Equal Weight → Overweight
2021-08-13	Aggiornamento	Raymond James	Mkt Perform → Outperform
2021-05-28	Iniziato	Robert W. Baird	Neutral
2021-04-06	Ripresa	Evercore ISI	Outperform
2021-01-25	Iniziato	Guggenheim	Buy
2020-11-19	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2020-11-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-10-19	Iniziato	Barclays	Equal Weight
2020-10-19	Iniziato	BofA Securities	Neutral
2020-10-19	Iniziato	Citigroup	Buy
2020-10-19	Iniziato	Cowen	Outperform
2020-10-19	Iniziato	Credit Suisse	Outperform
2020-10-19	Iniziato	Deutsche Bank	Hold
2020-10-19	Iniziato	Goldman	Neutral
2020-10-19	Iniziato	JP Morgan	Neutral
2020-10-19	Iniziato	Morgan Stanley	Overweight
2020-10-19	Iniziato	RBC Capital Mkts	Sector Perform
2020-10-19	Iniziato	SVB Leerink	Outperform
2020-10-19	Iniziato	UBS	Buy

Mostra tutto

GoodRx Holdings Inc Borsa (GDRX) Ultime notizie

Is GoodRx (GDRX) Outperforming Other Medical Stocks This Year?

Zacks Investment Research

GoodRx Holdings Analyst Turns Bullish Ahead Of Q1 Earnings

Benzinga

ELV vs. GDRX: Which Stock Is the Better Value Option?

Zacks Investment Research

Why GoodRx Surged Today

The Motley Fool

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Telemedicine GoodRx Has Potential To Excel, Close Valuation Gap By 2025, Analyst Says

Benzinga

GoodRx Holdings Inc Azioni (GDRX) Dati Finanziari

GoodRx Holdings Inc (GDRX) Reddito 2024

GoodRx Holdings Inc (GDRX) Reddito netto 2024

GoodRx Holdings Inc (GDRX) Flusso di cassa 2024

GoodRx Holdings Inc (GDRX) Utile per azione 2024

GoodRx Holdings Inc Azioni (GDRX) insider trading